Clinical trial
A Phase 1 Study of ARC101 in Advanced Solid Tumors
NCT06672185 is registered in ClinicalTrials.gov with Third Arc Bio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of ARC101 in Advanced Solid Tumors
- Lead sponsor
- Third Arc Bio
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- February 5, 2025
- Completion date
- August 1, 2028
- Enrollment
- 70 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
advanced solid tumor